|
|
| |
|
|
AmtixBio aims to develop next-generation antifungal drugs through multi-omics based cutting-edge technologies. Our company also aims to develop novel natural antimicrobial products and diverse microbial biomaterials through molecular biological and genetic approaches.
We have studied 3 years or more to prepare innovative Dermacosmetic products with the prominent scientists.
We have screened and identified the special ONE proboitic Lactic Acid Bacteria from 3,000 or more probiotic microorganisms living in Korean super foods.
Ambling probiotic Dermacosmetic products provide credible natural preservation system, without toxic chemical preservatives, such as, pareben, and sodium benzoate, etc.
Our unique materials of culture extracts of Probiotic Lactic Acid Bacteria help to maintain the most optimal skin microbiome balance.
Our unique materials improve skin barrier functions by increasing the expression levels of important proteins consisting of Tight Junction in skin barrier.
|
[ Buying Categories ]
|
[ Selling Categories ]
|
[ keyword ]
|
 Registration Date |
2019/11/05 (Year/Month/Date) |
| Buyer / Seller in EC21 |
Seller |
| Business Type |
Manufacturer |
| Year established |
2015 |
| Employees total |
11 - 50 |
| Annual revenue |
Less than USD 100,000 |
|
Contact Information |
 |
|
| Company |
AMTIXBIO Co., Ltd. |
| Address |
A-513, 11, Beobwon-ro 11-gil Songpa-gu Seoul Korea |
| Phone |
82 - 2 - 21486530 |
| Fax |
82 - 2 - 21486550 |
| Homepage |
|
| Contact |
Jeon Minkyung
|
|
|
Trade Information |
| Export Percentage type |
71 ~ 80% |
| Exporting Started Year |
2019 |
| Annual Export Value (USD) |
Choose not to Disclose |
| Annual Import Value (USD) |
Choose not to Disclose |
| Export Market |
Asia
|
|
|
|
|
|
|
|
| |
|
|
|
Facebook
Twitter
Delicious
Google
Digg
Reddit
My EC21
Email this page
EC21 Mobile Web